REFERENCES
- Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 2012;64(10):3061–3067
- Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumour. In: WHO Classification of Tumours. Tumours of Soft Tissue and Bone. CDM Fletcher, K Unni, Mertens F, eds. Lyon France: IARC Press, 2002;91–93
- Polito E, Pichierri P, Loffredo A, et al. Inflammatory myofibroblastic tumor of the orbit. Ophthalmologica 2007; 221:353–355
- Saab ST, Hornick JL, Fletcher CD, et al. IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link? Mod Pathol. 2011;24(4):606–612
- Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol 2011;64(3):237–243
- Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 2001;25:1364–1371